TRAVERE THERAPEUTICS Logo (WIPO, 25.06.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke TRAVERE THERAPEUTICS wurde als Wortmarke am 25.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1543170 |
| Länder | 
|
| Basismarke |
Nr. 88758429,
14. Januar 2020
|
| Anmeldedatum | 25. Juni 2020 |
| Ablaufdatum | 25. Juni 2030 |
Markeninhaber
3611 Valley Centre Drive, Suite 300
San Diego CA 92130
US
San Diego CA 92130
US
Markenvertreter
701 Fifth Avenue, Suite 5400
Seattle WA 98104
US
Waren und Dienstleistungen
05
Pharmaceutical preparations for the prevention of liver
diseases and disorders; pharmaceutical preparations for the
treatment of liver diseases and disorders; pharmaceutical
preparations for the prevention of kidney diseases and
disorders; pharmaceutical preparations for the treatment of
kidney diseases and disorders; pharmaceutical preparations
for the prevention of central nervous system diseases and
disorders; pharmaceutical preparations for the treatment of
central nervous system diseases and disorders;
pharmaceutical preparations for the prevention of monogenic
diseases and disorders; pharmaceutical preparations for the
treatment of monogenic diseases and disorders;
pharmaceutical preparations for the prevention of metabolic
diseases and disorders; pharmaceutical preparations for the
treatment of metabolic diseases and disorders; therapeutic
preparations for the prevention of liver diseases and
disorders; therapeutic preparations for the treatment of
liver diseases and disorders; therapeutic preparations for
the prevention of kidney diseases and disorders; therapeutic
preparations for the treatment of kidney diseases and
disorders; therapeutic preparations for the prevention of
central nervous system diseases and disorders; therapeutic
preparations for the treatment of central nervous system
diseases and disorders; therapeutic preparations for the
prevention of monogenic diseases and disorders; therapeutic
preparations for the treatment of monogenic diseases and
disorders; therapeutic preparations for the prevention of
metabolic diseases and disorders; therapeutic preparations
for the treatment of metabolic diseases and disorders
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 14. Dezember 2022 | 2023/2 Gaz | CA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 31. Mai 2022 | 2022/22 Gaz | MX | Ablehnung |
| 22. Februar 2022 | 2022/8 Gaz | IS | Ablehnung |
| 26. November 2021 | 2021/49 Gaz | CA | Ablehnung |
| 23. September 2021 | 2021/38 Gaz | CH | Ablehnung |
| 23. September 2021 | 2021/38 Gaz | NO | Ablehnung |
| 24. August 2021 | 2021/35 Gaz | KR | Ablehnung |
| 29. Juli 2021 | 2021/30 Gaz | JP | Ablehnung |
| 23. Juli 2021 | 2021/39 Gaz | CO | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 08. Juli 2021 | 2021/30 Gaz | IL | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 19. März 2021 | 2021/12 Gaz | NZ | Ablehnung |
| 15. Februar 2021 | 2021/7 Gaz | IN | Ablehnung |
| 31. Januar 2021 | 2021/6 Gaz | CO | Ablehnung |
| 01. Januar 2021 | 2021/1 Gaz | SG | Ablehnung |
| 23. Dezember 2020 | 2020/53 Gaz | TR | Ablehnung |
| 22. Dezember 2020 | 2020/52 Gaz | AU | Ablehnung |
| 16. Dezember 2020 | 2020/51 Gaz | EM | Ablehnung |
| 27. November 2020 | 2020/49 Gaz | RU | Ablehnung |
| 26. November 2020 | 2020/48 Gaz | CN | Ablehnung |
| 11. November 2020 | 2020/46 Gaz | GB | Ablehnung |
| 04. November 2020 | 2020/46 Gaz | IL | Ablehnung |
| 09. Oktober 2020 | 2020/43 Gaz | US | Korrektur |
| 25. Juni 2020 | 2020/29 Gaz | US | Eintragung |
ID: 141543170